Nutrition 21 Securities Not In Compliance With Nasdaq $1.00 Minimum Bid Price Rule

PURCHASE, N.Y., June 10, 2005-Nutrition 21, Inc. (NASDAQ: NXXI) today announced that it received a Nasdaq Staff letter that states that the Company has failed to comply with the $1.00 minimum bid price requirement for continued listing set forth in Marketplace Rule 4310(c)(4), and that the Company is being provided 180 calendar days, or until December 5, 2005, to regain compliance.  If the Company continues to meet all other listing requirements as of December 5, 2005, the Company will be granted an additional 180 calendar days to regain compliance with the minimum bid price requirement. If the Company does not regain compliance with the minimum bid price requirement, its securities will be delisted.

About Nutrition 21
Nutrition 21 is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research.  The company markets Chromax® chromium picolinate, which is the most-studied form of the essential mineral chromium.  Nutrition 21 also developed Diachrome®, which is available through diabetes educators or at www.diachrome.com.  Nutrition 21 holds 36 patents for nutrition products and uses, 27 of which are for chromium compounds and their uses.  More information is available at www.nutrition21.com.